Cadila expands oncology portfolio with biosimilar cancer drug Bevaro™

Cadila expands oncology portfolio with Bevasizumab biosimilar cancer drug Bevaro™ used in the treatment of multiple cancers . Ahmedabad-based Cadila Pharmaceuticals Limited recently announced the launch of Bevasizumab biosimilar for

Read More

shugreek diabetes tablets-medifield

 

 

Jodarin-pain-cream

 

 

Magazines

SUBSCRIBE MAGAZINE

Click Here

error: Content is protected !!